Seven West Media has shown a notable focus on ASX-listed medtech company Orthocell. This Perth-based firm specializes in cell regeneration therapies and was spun out of the University of Western Australia in 2007.
Orthocell's market capitalization hovers around $300 million and has increased by approximately 80% over the past year, marking it as a steady performer among many smaller medtech firms on the ASX.
"Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies."
The company, while relatively small in the sector, continues to attract attention due to its promising growth and innovations.